Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 26, 1206 (1 November 2008) | doi:10.1038/nbt1108-1206b
Enbrel patent feud
Abstract
The University of Iowa and University of Iowa Research Foundation (UIRF) are suing Amgen, of Thousand Oaks, California, for patent violation. According to the complaint, Amgen and its affiliates “have for many years infringed the Iowa Patents with full knowledge of them” to produce Enbrel (etanercept) and Vectibix (panitumumab).
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
